Christy Ralph
St James's University Hospital(GB)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Virus-based gene therapy research, CAR-T cell therapy research, Renal and related cancers, Prostate Cancer Treatment and Research
Most-Cited Works
- → DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer(2015)2,165 cited
- → Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial(2019)636 cited
- → Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade(2018)373 cited
- → Genomics of lethal prostate cancer at diagnosis and castration resistance(2019)295 cited
- → Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma(2010)249 cited
- → Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma(2016)127 cited
- → A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer(2015)98 cited
- → Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial(2023)77 cited
- → Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO)(2023)75 cited
- → Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells(2010)73 cited